MedTrace Logo

Fecal Microbiota Transplantation for Ulcerative Colitis

NCT03016780 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-01-11

No results posted yet for this study

Summary

Ulcerative colitis is a common digestive system disease, the incidence is increasing in recent years.It is reported that the occurrence and development of ulcerative colitis is closely related to imbalance of intestinal flora .Moreover,intestinal mucosal immunity may be related to intestinal flora. Fecal microbiota transplantation as a new technology to rebuild intestinal flora has been used for several disease，but the efficacy of ulcerative colitis by fecal microbiota transplantation needs to be further explored.

Conditions

  • Ulcerative Colitis
  • Intestinal Bacteria Flora Disturbance
  • Fecal Microbiota Transplantation

Interventions

OTHER

Fecal Microbiota Transplantation

Fecal microbiota transplantation and the traditional treatments for ulcerative colitis in part 1.

OTHER

Normal Saline

Normal saline and the traditional treatments for ulcerative colitisin in part 2.

Sponsors & Collaborators

  • First Affiliated Hospital of Chengdu Medical College

    lead OTHER

Principal Investigators

  • Xiaoan Li, Ph.D · First Affiliated Hospital of Chengdu Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-07-31
Completion
2019-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03016780 on ClinicalTrials.gov